Perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate

Catalog No. :
ACYCGL510
CAS No. :
2101206-48-6
Molecular Formula :
C26H30F5NO7
Molecular Weight :
563.52

IUPAC Name:perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate

Perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePerfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate
IUPAC Nameperfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate
Molecular FormulaC26H30F5NO7
Molecular Weight563.52
SMILESO=C(OC1=C(F)C(F)=C(F)C(F)=C1F)CCOCCOCCOCCNC(OCC2C3CCC#CCCC23)=O
InChI KeyKXWYFDXVBMIXQH-UHFFFAOYSA-N
Synonym5,8,11-Trioxa-2-azatetradecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 14-(2,3,4,5,6-pentafluorophenyl) ester;BCOT-PEF3-OPFP
CAS No.2101206-48-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYCGL510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVQAC527 route compound structure diagram
    ACVQAC527771-61-9 In Stock
  4. Then
  5. ACYCGL510 route product structure diagram
    ACYCGL5102101206-48-6
Inquiry

2. ACYCGL510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJBSC904 route compound structure diagram
    ACJBSC9041379662-52-8 In Stock
  4. Then
  5. ACYCGL510 route product structure diagram
    ACYCGL5102101206-48-6
Inquiry

Comments (0)